ccampbell

Oncolytic viruses (OVs) are promising therapeutic tools for solid tumors due to their many biological advantages compared to traditional approaches including: (1) the selective replication of the OVs in cancer cells without affecting normal cells; (2) the lack of resistance mechanism by the targeted cells and (3) the capacity of the OV to spread throughout [...]

Weill Cornell Medicine In 2014, The TLC Foundation announced the launch of a new pediatric brain tumor research fellowship at the Weill Cornell Medicine Children’s Brain Tumor Project. Led by Co-Directors Dr. Mark Souweidane and Dr. Jeffrey Greenfield, The Children’s Brain Tumor Project shares our mission to improve the outcome for children with brain tumors by advancing scientific [...]

Phase 2 International Clinical Trial Multiple Centers (originally led by Memorial Sloan Kettering Cancer Center) What began as a proposal for a clinical trial in four centers, has expanded into a worldwide clinical trial. In 2016, the TLC Foundation, in collaboration with like-minded nonprofits A Kids' Brain Tumor Cure and Solving Kids' Cancer, provided the [...]

The Ty Louis Campbell (TLC) Foundation partnered with the St. Baldrick’s Foundation to support a three-year preclinical research project led by Dr. Samuel Cheshier at Stanford University and Huntsman Cancer Institute, providing $330,000 in funding. Based on highly promising preclinical results, TLC also contributed $15,000 in seed funding to help launch a Phase 1 clinical [...]